STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

Hims & Hers (HIMS) CEO Andrew Dudum shifts insider HIMS holdings among family trusts

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Hims & Hers Health, Inc. (HIMS) CEO Andrew Dudum, a director and more than 10% owner, reported changes in his Class A common stock holdings dated 11/28/2025. The filing shows internal transfers among his direct ownership and various family trusts, including a transfer of 712,500 shares from the Andrew Dudum 2015 Trust to his direct holdings and an annuity payment-in-kind of 115,996 shares from the AD 2022 GRAT 3 to that trust.

The report also discloses a gift of 1,078,549 shares from the AD 2022 GRAT 3 to the Dudum Legacy 2021 Trust, recorded at a price of $0 with transaction code "G" (gift). After these movements, Dudum continues to hold a significant stake in Hims & Hers through a combination of direct ownership and multiple family and GRAT trusts.

Positive

  • None.

Negative

  • None.

Insights

CEO Andrew Dudum restructured HIMS equity among personal and family trusts via non-cash transfers and gifts.

The disclosure shows Andrew Dudum, as director, CEO, and more than 10% owner, adjusting how his Hims & Hers Class A shares are held. Key movements include a transfer of 712,500 shares from the Andrew Dudum 2015 Trust into his direct holdings and an annuity payment-in-kind of 115,996 shares from the AD 2022 GRAT 3 to that trust. These are typical estate and tax planning tools that shift where shares sit without involving market purchases or sales.

The filing also records a gift of 1,078,549 shares from the AD 2022 GRAT 3 to the Dudum Legacy 2021 Trust at a reported price of $0, coded "G" for gift. After these transactions, Dudum remains a large beneficial owner with interests spread across several GRATs and family trusts. The overall pattern is consistent with personal wealth and estate structuring rather than a change in his general exposure to Hims & Hers.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Dudum Andrew

(Last) (First) (Middle)
2269 CHESTNUT STREET, #523

(Street)
SAN FRANCISCO CA 94123

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Hims & Hers Health, Inc. [ HIMS ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director X 10% Owner
X Officer (give title below) Other (specify below)
Chief Executive Officer
3. Date of Earliest Transaction (Month/Day/Year)
11/28/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Class A Common Stock 805,023(1) D
Class A Common Stock 384,731(2) I Held by Trustee of Andrew Dudum 2015 Trust Dated July 2, 2015
Class A Common Stock 1,078,549(3) I Held by Trustee of AD 2022 GRAT 3 dated 11-28-2022
Class A Common Stock 11/28/2025 G 1,078,549(4) D $0 0 I Held by Trustee of AD 2022 GRAT 3 dated 11-28-2022
Class A Common Stock 11/28/2025 G 1,078,549(4) A $0 1,080,972 I Held by Trustee of Dudum Legacy 2021 Trust
Class A Common Stock 508,030 I Held by Trustee of AD 2022 GRAT
Class A Common Stock 186,723 I Held by Trustee of AD 2025 GRAT dated 5-27-2025
Class A Common Stock 47,524 I Held by Trustee of Dudum Family Community Property Trust
Class A Common Stock 791,117 I Held by Trustee of AD 2022 GRAT 2 dated 9/7/2022
Class A Common Stock 2,214,769 I Held by Trustee of Dudum Family Heritage Trust UAD 8-10-2021
Class A Common Stock 3,004,071 I Held by Trustee of Dudum Family 2021 Trust
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. This amount reflects a transfer of 712,500 shares of Class A Common Stock from the Andrew Dudum 2015 Trust dated July 2, 2015 to the Reporting Person's direct holdings.
2. This amount reflects 1) an annuity payment-in-kind of 115,996 shares of Class A Common Stock from the AD 2022 GRAT 3 dated 11-28-2022 to the Andrew Dudum 2015 Trust dated July 2, 2015 and 2) a transfer of 712,500 shares of Class A Common Stock to the Reporting Person's direct holdings.
3. This amount reflects an annuity payment-in-kind of 115,996 shares of Class A Common Stock to the Andrew Dudum 2015 Trust dated July 2, 2015 from the AD 2022 GRAT 3 dated 11-28-2022.
4. These shares represent a gift to the Dudum Legacy 2021 Trust from the AD 2022 GRAT 3 dated 11-28-2022.
Remarks:
/s/ Kimberly Mather, Attorney-in-Fact for Andrew Dudum 12/02/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did HIMS CEO Andrew Dudum report in this Form 4 filing?

The filing reports non-cash changes in Andrew Dudums beneficial ownership of Hims & Hers Class A common stock on 11/28/2025, mainly transfers and gifts among his direct holdings and various family and GRAT trusts.

Did Andrew Dudum sell HIMS shares for cash in this Form 4?

The disclosed transactions include a gift of 1,078,549 shares at a reported price of $0 and transfers and annuity payments-in-kind among trusts and direct holdings, rather than open-market sales for cash.

How many HIMS shares were transferred to Andrew Dudums direct holdings?

The explanation states that 712,500 shares of Class A common stock were transferred from the Andrew Dudum 2015 Trust to Andrew Dudums direct holdings.

What is the 1,078,549-share transaction involving HIMS stock?

The filing shows 1,078,549 shares of Class A common stock moved from the AD 2022 GRAT 3 as a gift to the Dudum Legacy 2021 Trust, reported with transaction code "G" and a price of $0.

How is Andrew Dudums HIMS ownership structured after these transactions?

After the reported activity, Dudum beneficially owns Hims & Hers shares directly and through multiple entities, including the Andrew Dudum 2015 Trust, several AD 2022 GRAT vehicles, the Dudum Legacy 2021 Trust, and other family trusts listed in Table I.

Why does HIMS classify Andrew Dudum as a 10% owner in this Form 4?

The form identifies Andrew Dudum as a director, Chief Executive Officer, and 10% owner, reflecting that his aggregate beneficial holdings across direct ownership and trusts exceed 10% of Hims & Hers' outstanding Class A common stock.
Hims & Hers Health Inc

NYSE:HIMS

HIMS Rankings

HIMS Latest News

HIMS Latest SEC Filings

HIMS Stock Data

8.54B
204.91M
10.63%
88.99%
33.02%
Household & Personal Products
Services-offices & Clinics of Doctors of Medicine
Link
United States
SAN FRANCISCO